26 BioPharm International
®
Manufacturing and Facilities eBook 2023 www.biopharminternational.com
A
s the biopharmaceutical industry moves
into the end of 2023, biopharmaceutical
companies should take stock of the latest
developments in biopharmaceutical man-
ufacturing and facilities. Over the past few months,
manufacturing has seen many facility expansions
and openings throughout the globe, partnerships
for outsourcing services, and various acquisitions
and expansions of manufacturing companies.
Partnerships
A crucial component of manufacturing is the collab-
orations between sponsors and contract manufactur-
ing organizations (CMOs). For investors and industry
professionals interested in outsourcing services, it is
beneficial to take a look at partnerships between both
long-trusted and up-and-coming biopharmaceutical
companies and CMOs. In early September, Recipharm
announced a partnership with Ahead Therapeutics,
a Spanish start-up biotech company, to work on the
development of a therapy for a rare autoimmune dis-
ease, myasthenia gravis (1). ScaleReady and CTMC's
partnership, also related to cell and gene therapy,
took a broader approach, focusing on the manufac-
turing barriers surrounding life-saving cell and gene
therapies (2). The companies released a statement on
October 4, expressing their intent to integrate cut-
ting-edge automation tools to help these therapies
reach more patients.
On Oc tober 9, GSK a n nou nced a pa r t ner sh ip
w it h Chongqing Zh ifei Biologics Products Co. to
co-promote GSK's sh ingles vacci ne, Sh i ngr i x, in
China, broadening the availability of the vaccine (3).
Forge Biologics, a US-based CDMO, joined the Califor-
nia Institute for Regenerative Medicine's Industry Re-
source Partner Program in order to manufacture ad-
eno-associated adenovirus vectors for gene therapy
programs (4). Genetech and PeptiDream announced
a collaboration to discover and develop novel macro-
cycle peptide-radioisotope drug conjugates (5).
Update on Facilities and
Manufacturing Trends
Daria Husni
is assistant editor at
BioPharm International
®
This article presents the latest developments in
biopharmaceutical manufacturing and facilities.
PRASANTH
-
STOCK.ADOBE.COM
